Stealth BioTherapeutics (Stealth BioTherapeutics) Additional Paid-In Capital : $0.00 Mil(As of Mar. 2022)

View and export this data going back to 2019. Start your Free Trial

What is Stealth BioTherapeutics Additional Paid-In Capital?

Stealth BioTherapeutics's quarterly additional paid-in capital increased from Sep. 2021 ($0.00 Mil) to Dec. 2021 ($562.47 Mil) but then stayed the same from Dec. 2021 ($562.47 Mil) to Mar. 2022 ($0.00 Mil).

Stealth BioTherapeutics's annual additional paid-in capital increased from Dec. 2019 ($515.13 Mil) to Dec. 2020 ($544.89 Mil) and increased from Dec. 2020 ($544.89 Mil) to Dec. 2021 ($562.47 Mil).

Stealth BioTherapeutics Additional Paid-In Capital Historical Data

The historical data trend for Stealth BioTherapeutics's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stealth BioTherapeutics Additional Paid-In Capital Chart

Stealth BioTherapeutics Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Additional Paid-In Capital

Get a 7-Day Free Trial

38.25

39.54

515.13

544.89

562.47

Stealth BioTherapeutics Quarterly Data
	Dec16	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22
Additional Paid-In Capital	Get a 7-Day Free Trial															-	555.03	-	562.47	-

Stealth BioTherapeutics Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Stealth BioTherapeutics Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Stealth BioTherapeutics's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Stealth BioTherapeutics (Stealth BioTherapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Stealth BioTherapeutics Corp (NAS:MITO) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

c/o Intertrust Corporate Services (Cayman) Limited, One Nexus way, Camana Bay, Grand Cayman, CYM, KY1-9005

Website

https://www.stealthbt.com

Stealth BioTherapeutics Corp is a clinical-stage biotechnology company. It is focused on the discovery, development, and commercialization of novel therapies for diseases involving mitochondrial dysfunction.